MedTrace Logo

Dose-to-block Level Relation in Single Shot Spinal Anesthesia for Cesarean Section.

NCT06729567 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 362

Last updated 2025-07-22

No results posted yet for this study

Summary

The study is designed to support or deny relation between the dose of hyperbaric bupivacaine given intrathecally and extent of spinal block level. There is ongoing debate whether anesthetists should adjust the dose in the range of conventional doses in order to achieve appropriate coverage of anesthesia which would be suitable for cesarean section.

Two strategies are predominantly used: low dose strategy, which is focused on safety, and conventional dose approach, which is more effective in terms of success of anesthesia, with markedly higher rate of spinal block - related complications. It is hypothesized that there may be no relation between block level and the dose if conventional doses are used. For that purpose anesthetic charts of cesarean sections will be reviewed to gather information on the doses of anesthetic used and the level of spinal block they produced.

Conditions

  • Spinal Anesthesia Evaluation
  • Cesarean Delivery

Interventions

OTHER

Spinal block level analysis

Relation of the dose of hyperbaric bupivacaine to resulting spinal block level is to be assessed. Conventional dose cases (more than 9mg and less than 13mg) will be included in analysis.

OTHER

data collection

Intervention is to acquire and analyse anonymous perioperative data. After identification of the eligible cases, statistical analysis will be performed.

Sponsors & Collaborators

  • Centre of Postgraduate Medical Education

    lead OTHER

Principal Investigators

  • Malgorzata Malec-Milewska, MD, Prof. · Department of Anesthesia and Intensive Care, Orlowski Hospital, Warsaw

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-20
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06729567 on ClinicalTrials.gov